Complete Filing Data
Oncology Institute, Inc. reported Stockholders Equity of -$15.72 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Oncology Institute, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$60.6M | -$64.7M | -$83.1M | $152.0K | -$10.9M | -$14.3M |
| Operating Income Loss | -$36.1M | -$60.1M | -$77.0M | -$82.0M | -$45.9M | -$8.2M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$60.7M | -$64.7M | -$83.1M | -$91.0K | -$11.6M | -$14.8M |
| Income Tax Expense Benefit | -$131.0K | $0.00 | -$36.0K | -$243.0K | -$671.0K | -$493.0K |
| Selling General And Administrative Expense | $105.6M | $107.8M | $113.9M | $119.7M | $83.4M | $41.9M |
| Revenue From Contract With Customer Excluding Assessed Tax | $502.7M | $393.4M | $324.2M | $252.5M | $203.0M | $187.5M |
| Other Nonoperating Income Expense | -$925.0K | -$365.0K | -$704.0K | $501.0K | $1.0M | -$6.3M |
| Nonoperating Income Expense | -$24.7M | -$4.5M | -$6.1M | $81.9M | $34.3M | -$6.6M |
| Deferred Income Tax Expense Benefit | -$32.0K | $0.00 | -$76.0K | -$263.0K | -$1.2M | -$1.3M |
| Deferred Income Tax Liabilities Net | $0.00 | $32.0K | $32.0K | $108.0K | $371.0K | $1.6M |
| Income Taxes Paid Net | $0.00 | $403.0K | $150.0K | $1.7M | $207.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$16.5M | -$17.0M | -$19.6M | -$16.1M | -$15.5M | -$19.9M | -$17.4M | -$16.9M | -$30.0M | -$2.7M | -$5.5M | $19.3M | -$3.0M | $3.2M | -$996.0K | -$2.4M | -$2.6M | -$776.8K | -$2.3K |
| Operating Income Loss | -$8.1M | -$11.2M | -$9.9M | -$13.9M | -$16.4M | -$18.0M | -$13.9M | -$14.9M | -$32.9M | -$20.1M | -$18.3M | -$18.5M | -$2.2M | -$1.1M | -$1.8M | -$198.5K | -$194.6K | -$87.8K | -$2.3K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$16.5M | -$17.1M | -$19.6M | -$16.1M | -$15.5M | -$19.9M | -$17.3M | -$16.8M | -$30.0M | -$2.7M | -$5.5M | $19.5M | -$2.2M | $4.0M | -$778.0K | -$2.4M | -$2.6M | -$2.3K | |
| Income Tax Expense Benefit | $0.00 | -$131.0K | $0.00 | $0.00 | $0.00 | $0.00 | $135.0K | $99.0K | $44.0K | -$24.0K | -$32.0K | $180.0K | $799.0K | $780.0K | $218.0K | $12.6K | $0.00 | ||
| Selling General And Administrative Expense | $25.3M | $26.9M | $25.4M | $26.6M | $27.9M | $28.5M | $28.2M | $28.7M | $28.8M | $32.0M | $28.3M | $29.8M | $12.7M | $11.2M | $11.2M | ||||
| Revenue From Contract With Customer Excluding Assessed Tax | $136.6M | $119.8M | $104.4M | $99.9M | $98.6M | $94.7M | $82.0M | $80.2M | $76.2M | $65.0M | $60.9M | $55.2M | $52.3M | $49.8M | $48.6M | ||||
| Other Nonoperating Income Expense | -$403.0K | -$19.0K | -$752.0K | -$55.0K | -$117.0K | $68.0K | -$140.0K | -$357.0K | $143.0K | -$36.0K | $15.0K | -$151.0K | $54.0K | -$4.0K | $1.1M | ||||
| Nonoperating Income Expense | -$8.5M | -$5.9M | -$9.7M | -$2.3M | $885.0K | -$1.9M | -$3.4M | -$1.9M | $2.9M | $17.4M | $12.8M | $37.9M | -$24.0K | $5.1M | $975.0K | ||||
| Deferred Income Tax Expense Benefit | $0.00 | -$26.0K | $180.0K | $221.0K | |||||||||||||||
| Deferred Income Tax Liabilities Net | $0.00 | $0.00 | $32.0K | $32.0K | $32.0K | $32.0K | $158.0K | $78.0K | $82.0K | $554.0K | $502.0K | $551.0K | |||||||
| Income Taxes Paid Net | $0.00 | $68.0K | $0.00 | $4.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$15.7M | $3.6M | $57.0M | $123.2M | $104.2M | $28.1M | $42.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $33.6M | $49.7M | $33.5M | $14.0M | $115.2M | $6.0M | $2.4M |
| Assets | $164.7M | $172.7M | $209.2M | $261.7M | $203.4M | $65.7M | $50.0K |
| Retained Earnings Accumulated Deficit | -$271.4M | -$210.8M | -$146.2M | -$63.1M | -$63.2M | -$52.3M | -$2.3K |
| Liabilities | $180.4M | $169.1M | $152.2M | $138.5M | $99.3M | $37.6M | $27.3K |
| Liabilities And Stockholders Equity | $164.7M | $172.7M | $209.2M | $261.7M | $203.4M | $65.7M | $50.0K |
| Liabilities Current | $71.0M | $52.2M | $34.8M | $29.7M | $29.8M | $28.6M | $27.3K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$16.1M | $16.2M | $19.5M | -$101.2M | $109.2M | $3.6M | |
| Assets Current | $112.7M | $112.4M | $143.5M | $130.4M | $154.1M | $29.7M | $25.0K |
| Accrued Liabilities Current | $20.6M | $21.1M | $14.0M | $14.6M | $13.9M | $9.5M | $26.5K |
| Accounts Payable Current | $43.2M | $24.3M | $14.4M | $9.4M | $15.6M | $12.6M | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$271.0K | $30.0K | -$21.0K | $0.00 | -$60.0K | |
| Payment For Contingent Consideration Liability Financing Activities | $50.0K | $2.4M | $2.6M | $509.0K | $50.0K | $0.00 | |
| Property Plant And Equipment Net | $10.7M | $11.9M | $10.9M | $8.5M | $4.2M | $2.1M | |
| Other Receivables Net Current | $322.0K | $346.0K | $551.0K | $617.0K | $1.2M | $113.0K | |
| Other Liabilities Noncurrent | $28.0K | $125.0K | $365.0K | $868.0K | $6.9M | $807.0K | |
| Other Assets Noncurrent | $606.0K | $589.0K | $561.0K | $477.0K | $320.0K | $122.0K | |
| Inventory Net | $16.9M | $10.0M | $13.7M | $9.3M | $6.4M | $4.4M | |
| Intangible Assets Net Excluding Goodwill | $11.0M | $14.8M | $17.9M | $18.0M | $18.2M | $19.5M | |
| Goodwill | $7.2M | $7.2M | $7.2M | $21.4M | $26.6M | $14.2M | |
| Common Stock Value | $10.0K | $8.0K | $8.0K | $7.0K | $7.0K | $6.0K | |
| Accounts Receivable Net Current | $59.0M | $48.3M | $42.4M | $39.8M | $20.0M | $17.1M | |
| Gains Losses On Extinguishment Of Debt | $0.00 | $183.0K | $5.0M | $0.00 | |||
| Derivative Warrant Liabilities Noncurrent | $264.0K | $17.0K | $636.0K | $350.0K | $2.2M | $0.00 | |
| Derivative Liabilities Noncurrent | $12.6M | $385.0K | $3.1M | $4.0M | $0.00 | $0.00 | |
| Operating Lease Right Of Use Asset | $22.4M | $25.8M | $29.2M | $24.5M | $0.00 | ||
| Operating Lease Liability Noncurrent | $19.1M | $23.2M | $26.5M | $22.1M | $0.00 | ||
| Operating Lease Liability Current | $7.2M | $6.8M | $6.4M | $5.5M | $0.00 | ||
| Long Term Debt Noncurrent | $77.4M | $93.1M | $86.8M | $80.6M | $0.00 | $6.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$12.3M | -$9.0M | $5.1M | $15.5M | $29.2M | $41.3M | $71.8M | $84.7M | $98.4M | $127.9M | $124.0M | $132.0M | $47.5M | $50.4M | $47.1M | -$21.5M | -$19.1M | -$16.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $27.7M | $30.3M | $39.7M | $47.4M | $36.4M | $36.1M | $27.5M | $28.9M | $15.3M | $61.4M | $64.2M | $95.5M | $11.5M | $15.2M | $27.4M | $998.6K | $1.1M | $1.5M | |
| Assets | $163.6M | $159.8M | $164.0M | $179.2M | $179.6M | $204.5M | $218.4M | $230.0M | $234.6M | $283.8M | $189.7M | $206.5M | $230.3M | $230.8M | $231.0M | $231.4M | $231.5M | $231.8M | |
| Retained Earnings Accumulated Deficit | -$263.9M | -$247.4M | -$230.4M | -$197.6M | -$181.5M | -$166.0M | -$127.4M | -$110.0M | -$93.1M | -$52.1M | -$49.4M | -$43.9M | -$24.9M | -$8.8M | -$2.7M | -$300.8K | -$163.1K | -$47.4K | |
| Liabilities | $175.9M | $168.8M | $158.9M | $163.7M | $150.4M | $163.2M | $146.5M | $145.2M | $136.2M | $155.9M | $65.8M | $74.5M | $25.2M | $25.2M | $19.4M | $6.5M | $6.4M | $6.7M | |
| Liabilities And Stockholders Equity | $163.6M | $159.8M | $164.0M | $179.2M | $179.6M | $204.5M | $218.4M | $230.0M | $234.6M | $283.8M | $189.7M | $206.5M | $230.3M | $230.8M | $231.0M | $231.4M | $231.5M | $231.8M | |
| Liabilities Current | $65.6M | $64.8M | $59.5M | $46.8M | $35.1M | $45.8M | $32.4M | $33.5M | $30.1M | $32.9M | $36.1M | $31.5M | $3.6M | $2.5M | $171.6K | $196.9K | $130.6K | $390.9K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$9.9M | $2.6M | $1.2M | -$19.6M | $21.4M | $1.5M | $25.0K | ||||||||||||
| Assets Current | $110.1M | $104.8M | $106.8M | $116.4M | $116.2M | $141.2M | $152.7M | $104.1M | $119.0M | $143.6M | $112.2M | $139.8M | $287.1K | $747.2K | $736.2K | $1.2M | $1.3M | $1.8M | |
| Accrued Liabilities Current | $22.8M | $22.9M | $23.4M | $15.4M | $12.8M | $18.4M | $12.7M | $14.1M | $12.2M | $16.1M | $17.6M | $14.5M | $2.6M | $1.5M | $80.0K | $28.0K | $13.0K | $35.1K | |
| Accounts Payable Current | $35.6M | $34.9M | $29.3M | $24.6M | $15.8M | $21.0M | $13.3M | $13.1M | $11.9M | $11.2M | $13.9M | $12.6M | $961.1K | $961.7K | $24.7K | $1.3K | $288.3K | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$12.0K | $0.00 | -$14.0K | $0.00 | ||||||||||||||
| Payment For Contingent Consideration Liability Financing Activities | $0.00 | $409.0K | $409.0K | $0.00 | |||||||||||||||
| Property Plant And Equipment Net | $10.7M | $10.9M | $11.1M | $12.3M | $12.2M | $11.0M | $10.8M | $10.8M | $9.8M | $7.0M | $6.0M | $4.9M | |||||||
| Other Receivables Net Current | $339.0K | $276.0K | $346.0K | $358.0K | $350.0K | $368.0K | $464.0K | $499.0K | $428.0K | $559.0K | $422.0K | $1.3M | |||||||
| Other Liabilities Noncurrent | $3.0K | $10.0K | $117.0K | $133.0K | $179.0K | $273.0K | $459.0K | $553.0K | $765.0K | $970.0K | $3.1M | $3.8M | |||||||
| Other Assets Noncurrent | $586.0K | $586.0K | $591.0K | $588.0K | $582.0K | $568.0K | $560.0K | $557.0K | $527.0K | $461.0K | $407.0K | $332.0K | |||||||
| Inventory Net | $18.9M | $15.8M | $12.3M | $10.1M | $11.3M | $11.6M | $12.2M | $12.2M | $10.3M | $10.0M | $8.6M | $7.8M | |||||||
| Intangible Assets Net Excluding Goodwill | $11.7M | $12.4M | $14.0M | $15.6M | $16.4M | $17.1M | $18.6M | $19.3M | $17.2M | $18.7M | $19.4M | $17.6M | |||||||
| Goodwill | $7.2M | $7.2M | $7.2M | $7.2M | $7.2M | $7.2M | $7.2M | $7.2M | $4.6M | $31.0M | $34.5M | $26.6M | |||||||
| Common Stock Value | $10.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | |||||||
| Accounts Receivable Net Current | $59.6M | $55.7M | $49.3M | $54.5M | $54.0M | $58.8M | $48.4M | $46.4M | $46.0M | $34.8M | $28.9M | $24.5M | |||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $183.0K | $0.00 | $5.2M | $0.00 | ||||||||||
| Derivative Warrant Liabilities Noncurrent | $262.0K | $112.0K | $59.0K | $64.0K | $84.0K | $636.0K | $292.0K | $89.0K | $207.0K | $1.7M | $1.6M | $3.7M | |||||||
| Derivative Liabilities Noncurrent | $13.7M | $7.7M | $3.7M | $514.0K | $514.0K | $3.1M | $1.9M | $642.0K | $642.0K | $12.7M | $9.8M | $20.6M | |||||||
| Operating Lease Right Of Use Asset | $23.3M | $23.9M | $24.2M | $27.1M | $27.0M | $27.4M | $28.5M | $29.0M | $24.7M | $24.8M | $17.3M | $17.2M | |||||||
| Operating Lease Liability Noncurrent | $20.2M | $21.2M | $21.6M | $24.7M | $24.5M | $25.1M | $26.0M | $26.6M | $22.3M | $21.8M | $14.6M | $14.4M | |||||||
| Operating Lease Liability Current | $7.2M | $7.0M | $6.8M | $6.7M | $6.5M | $6.4M | $6.1M | $6.0M | $5.6M | $5.2M | $4.5M | $4.3M | |||||||
| Long Term Debt Noncurrent | $76.2M | $75.0M | $73.9M | $91.5M | $90.0M | $88.4M | $85.3M | $83.7M | $82.1M | $79.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$24.6M | -$26.5M | -$36.3M | -$61.8M | -$32.7M | $508.0K |
| Increase Decrease In Prepaid Expense | -$2.0M | -$1.2M | -$3.1M | -$4.3M | $9.1M | $1.4M |
| Increase Decrease In Accrued Liabilities | -$448.0K | $9.5M | $3.4M | $2.3M | -$3.1M | $5.2M |
| Net Cash Provided By Used In Investing Activities | -$3.1M | $46.2M | $62.6M | -$131.6M | -$12.2M | -$8.8M |
| Net Cash Provided By Used In Financing Activities | $11.6M | -$3.5M | -$6.8M | $92.2M | $154.0M | $11.9M |
| Increase Decrease In Accounts Payable | $19.6M | $9.2M | $5.1M | -$6.2M | $2.9M | $3.8M |
| Share Based Compensation | $4.6M | $11.2M | $17.8M | $27.7M | $24.5M | $151.0K |
| Payments To Acquire Property Plant And Equipment | $3.2M | $3.8M | $4.6M | $5.5M | $2.8M | $1.2M |
| Payments For Financing Of Insurance Payments | $991.0K | $1.2M | $3.3M | $5.0M | $409.0K | $0.00 |
| Increase Decrease In Other Receivables | $274.0K | -$205.0K | -$66.0K | -$620.0K | $792.0K | -$5.0K |
| Increase Decrease In Other Noncurrent Liabilities | -$11.0K | -$203.0K | -$443.0K | -$1.2M | $809.0K | $3.0K |
| Increase Decrease In Inventories | $6.8M | -$3.6M | $4.4M | $1.7M | $1.8M | $465.0K |
| Increase Decrease In Accounts Receivable | $12.3M | $6.0M | $4.6M | $20.3M | $2.2M | $6.8M |
| Depreciation Depletion And Amortization | $6.9M | $6.3M | $5.9M | $4.4M | $3.3M | $3.2M |
| Increase Decrease In Other Noncurrent Assets | $17.0K | $28.0K | $84.0K | $157.0K | $198.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q4 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$5.0M | $4.0M | -$15.9M | -$15.5M | -$17.0M | $464.0K | -$28.8K | $0.00 |
| Increase Decrease In Prepaid Expense | $1.1M | $629.0K | $24.0K | -$456.0K | -$56.0K | $57.9K | $0.00 | |
| Increase Decrease In Accrued Liabilities | $2.6M | $5.4M | -$805.0K | $526.0K | $358.0K | -$1.5K | $1.5K | |
| Net Cash Provided By Used In Investing Activities | -$202.0K | $19.4M | $18.4M | -$1.0M | -$1.4M | -$230.0M | $0.00 | |
| Net Cash Provided By Used In Financing Activities | -$4.7M | -$938.0K | -$1.7M | -$1.7M | $22.4M | $231.5M | $25.0K | |
| Increase Decrease In Accounts Payable | $5.1M | $6.4M | $2.6M | -$3.0M | $474.0K | $51.7K | ||
| Share Based Compensation | $1.5M | $4.1M | $5.0M | $8.6M | $42.0K | |||
| Payments To Acquire Property Plant And Equipment | $328.0K | $610.0K | $1.8M | $1.0M | $619.0K | |||
| Payments For Financing Of Insurance Payments | $226.0K | $1.0M | $1.3M | $1.2M | $0.00 | |||
| Increase Decrease In Other Receivables | $0.00 | -$183.0K | -$189.0K | $42.0K | $20.0K | |||
| Increase Decrease In Other Noncurrent Liabilities | $1.0K | -$82.0K | $316.0K | $0.00 | $362.0K | |||
| Increase Decrease In Inventories | $2.3M | -$2.1M | $993.0K | $1.3M | -$10.0K | |||
| Increase Decrease In Accounts Receivable | $985.0K | $16.4M | $6.1M | $4.7M | $550.0K | |||
| Depreciation Depletion And Amortization | $1.8M | $1.5M | $1.3M | $987.0K | $777.0K | |||
| Increase Decrease In Other Noncurrent Assets | $2.0K | $7.0K | $50.0K | $11.0K | $37.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 193.5K | 165.0K | 165.0K | 165.0K | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Issued | 193.5K | 165.0K | 165.0K | 165.0K | 163.5K | 0.00 | 0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 92.4M | 75.0M | 73.7M | 72.8M | 66.2M | 59.1M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 92.4M | 75.0M | 73.7M | 80.6M | 66.2M | 59.1M | ||
| Earnings Per Share Diluted | $-0.54 | $-0.71 | $-0.92 | $-0.21 | $-0.16 | $-0.24 | ||
| Earnings Per Share Basic | $-0.54 | $-0.71 | $-0.92 | $0.00 | $-0.16 | $-0.24 | ||
| Common Stock Shares Outstanding | 98.9M | 75.7M | 74.1M | 73.3M | 73.2M | 5.8M | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 400.0K | 20.0K | |
| Common Stock Shares Issued | 100.6M | 77.5M | 75.9M | 73.3M | 73.2M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 193.5K | 193.7K | 202.3K | 165.0K | 165.0K | 165.0K | 165.0K | 165.0K | 165.0K | 165.0K | 166.6K | 163.5K | 163.5K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Issued | 193.5K | 193.7K | 202.3K | 165.0K | 165.0K | 165.0K | 165.0K | 165.0K | 165.0K | 165.0K | 166.6K | 163.5K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 97.5M | 93.2M | 77.1M | 75.5M | 74.7M | 74.2M | 73.5M | 74.1M | 73.4M | 72.2M | 73.0M | 73.3M | 66.0M | 66.0M | 62.9M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 97.5M | 93.2M | 77.1M | 75.5M | 74.7M | 74.2M | 73.5M | 74.1M | 73.4M | 79.6M | 73.0M | 76.2M | 66.0M | 66.0M | 62.9M | ||||||
| Earnings Per Share Diluted | $-0.14 | $-0.15 | $-0.21 | $-0.18 | $-0.17 | $-0.22 | $-0.19 | $-0.19 | $-0.33 | $-0.17 | $-0.06 | $0.21 | $-0.05 | $0.05 | $-0.02 | ||||||
| Earnings Per Share Basic | $-0.14 | $-0.15 | $-0.21 | $-0.18 | $-0.17 | $-0.22 | $-0.19 | $-0.19 | $-0.33 | $-0.03 | $-0.06 | $0.22 | $-0.05 | $0.05 | $-0.02 | ||||||
| Common Stock Shares Outstanding | 97.6M | 93.3M | 88.9M | 75.6M | 75.5M | 74.3M | 73.7M | 73.0M | 73.8M | 72.3M | 72.0M | 73.3M | 23.0M | 23.0M | 23.0M | 23.0M | 5.8M | 5.8M | 5.8M | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |||||||||
| Common Stock Shares Issued | 99.3M | 95.0M | 90.7M | 77.3M | 77.2M | 76.0M | 75.5M | 74.5M | 73.8M | 72.3M | 72.0M | 73.3M | 23.0M | 23.0M | 23.0M | 23.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $247.0K | -$619.0K | $286.0K | -$1.8M | -$3.7M | $0.00 | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.6M | $11.2M | $17.8M | $27.4M | $24.5M | $151.0K | |
| Additional Paid In Capital | $256.7M | $215.4M | $204.2M | $186.3M | $167.4M | $80.4M | $24.4K |
| Operating Costs And Expenses | $538.8M | $453.5M | $401.3M | $334.4M | $248.9M | $195.7M | |
| Derivative Gain Loss On Derivative Net | -$12.2M | $2.7M | $878.0K | $24.2M | $0.00 | $0.00 | |
| Depreciation And Amortization | $6.9M | $6.3M | $5.9M | $4.4M | $3.3M | $3.2M | |
| Interest Paid Net | $3.9M | $4.5M | $4.5M | $224.0K | $275.0K | $227.0K | |
| Investment Income Interest | $254.1K | ||||||
| Amortization Of Financing Costs | $8.4M | $6.3M | $6.2M | $2.4M | $53.0K | $60.0K | |
| Prepaid Expense Current | $11.2M | $2.1M | |||||
| Provision For Doubtful Accounts | $0.00 | $2.0M | $476.0K | -$417.0K | $4.2M | ||
| Stock Issued During Period Value Stock Options Exercised | $2.8M | $75.0K | $126.0K | $858.0K | $50.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $150.0K | $53.0K | $43.0K | -$20.0K | -$552.0K | $0.00 | $203.0K | -$118.0K | -$143.0K | $159.0K | -$2.1M | $1.5M | $0.00 | $0.00 | $0.00 | $2.3M | $2.5M | $416.7K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.0M | $752.0K | $1.5M | $2.4M | $3.4M | $4.1M | $4.7M | $4.1M | $5.2M | $6.5M | $6.5M | $8.6M | $60.0K | $51.0K | $42.0K | |||||
| Additional Paid In Capital | $252.6M | $239.4M | $236.5M | $214.1M | $211.7M | $208.3M | $200.3M | $195.6M | $191.5M | $180.0M | $173.4M | $175.9M | $13.8M | $7.7M | $5.3M | $5.2M | $5.0M | |||
| Operating Costs And Expenses | $144.6M | $131.0M | $114.3M | $113.8M | $114.9M | $112.6M | $96.0M | $95.2M | $109.1M | $85.1M | $79.2M | $73.6M | $54.4M | $51.0M | $50.3M | |||||
| Derivative Gain Loss On Derivative Net | -$6.0M | -$4.0M | -$3.3M | $0.00 | $2.6M | $0.00 | -$1.3M | $0.00 | $3.3M | $15.5M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Depreciation And Amortization | $1.7M | $1.8M | $1.8M | $1.6M | $1.5M | $1.5M | $1.7M | $1.3M | $1.3M | $1.1M | $1.1M | $987.0K | $850.0K | $794.0K | $777.0K | |||||
| Interest Paid Net | $1.3M | $1.1M | $1.1M | $74.0K | $0.00 | |||||||||||||||
| Investment Income Interest | $5.8K | $6.7K | $46.0K | $73.4K | $78.8K | $43.0K | $0.00 | |||||||||||||
| Amortization Of Financing Costs | $4.9M | $1.6M | $1.5M | $0.00 | $18.0K | |||||||||||||||
| Prepaid Expense Current | $4.2M | $5.8M | $6.9M | $6.9M | $7.7M | $10.0M | $10.7M | $82.2K | $126.5K | $162.8K | $202.2K | $242.4K | $292.9K | |||||||
| Provision For Doubtful Accounts | $0.00 | $1.0K | $154.0K | $0.00 | ||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $355.0K | $2.2M | $137.0K | $2.0K | $73.0K | $13.0K | $79.0K | $337.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.